{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:16:42Z","timestamp":1788524202010,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Health and Medical Research Fund","award":["10212956 & 07182546"],"award-info":[{"award-number":["10212956 & 07182546"]}]},{"name":"Hong Kong Research Grants Council (RGC) General Research Fund","award":["17100021 & 17117019"],"award-info":[{"award-number":["17100021 & 17117019"]}]},{"name":"RGC Theme-based Research Scheme","award":["T12-716\/22-R"],"award-info":[{"award-number":["T12-716\/22-R"]}]},{"name":"RGC Collaborative Research Fund","award":["C5017-24G"],"award-info":[{"award-number":["C5017-24G"]}]},{"name":"Innovation and Technology Commission grant to the State Key Laboratory of Liver Research of the University of Hong Kong","award":["ITC PD\/17-9"],"award-info":[{"award-number":["ITC PD\/17-9"]}]},{"name":"NSFC grant","award":["82394451"],"award-info":[{"award-number":["82394451"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02682-x","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:16:11Z","timestamp":1780312571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Fanhong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanilla Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Man","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Man-Fong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan-To","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Wai-Hung","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-2029","authenticated-orcid":false,"given":"Irene Oi-Lin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2682_CR1","doi-asserted-by":"crossref","unstructured":"Jemal A et al. Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival. J Natl Cancer Inst 109(2017).","DOI":"10.1093\/jnci\/djx030"},{"key":"2682_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2682_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","volume":"58","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa K, et al. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol. 2013;58:724\u20139.","journal-title":"J Hepatol"},{"key":"2682_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A, Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"2682_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","volume":"15","author":"JM Llovet","year":"2018","unstructured":"Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15:599\u2013616.","journal-title":"Nat Rev Clin Oncol"},{"key":"2682_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"2682_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s43018-021-00234-4","volume":"2","author":"WJ Ho","year":"2021","unstructured":"Ho WJ, et al. Neoadjuvant cabozantinib and nivolumab converts locally advanced hcc into resectable disease with enhanced antitumor immunity. Nat Cancer. 2021;2:891\u2013903.","journal-title":"Nat Cancer"},{"key":"2682_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","volume":"19","author":"FS Hodi","year":"2018","unstructured":"Hodi FS, et al. Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19:1480\u201392.","journal-title":"Lancet Oncol"},{"key":"2682_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau T, et al. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2022;23:77\u201390.","journal-title":"Lancet Oncol"},{"key":"2682_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612:141\u20137.","journal-title":"Nature"},{"key":"2682_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang L, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181:442\u2013e459429.","journal-title":"Cell"},{"key":"2682_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829\u2013e845820.","journal-title":"Cell"},{"key":"2682_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao A, Barkley D, Fran\u00e7a GS, Yanai I. Exploring tissue architecture using spatial transcriptomics. Nature. 2021;596:211\u201320.","journal-title":"Nature"},{"key":"2682_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.ccell.2021.07.004","volume":"39","author":"EF Davis-Marcisak","year":"2021","unstructured":"Davis-Marcisak EF, et al. From bench to bedside: single-cell analysis for cancer immunotherapy. Cancer Cell. 2021;39:1062\u201380.","journal-title":"Cancer Cell"},{"key":"2682_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000531176","volume":"13","author":"TT Cheung","year":"2024","unstructured":"Cheung TT, et al. Multimodal integrative genomics and pathology analyses in neoadjuvant nivolumab treatment for intermediate and locally advanced hepatocellular carcinoma. Liver Cancer. 2024;13:70\u201388.","journal-title":"Liver Cancer"},{"key":"2682_CR16","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","volume":"12","author":"DW Ho","year":"2021","unstructured":"Ho DW, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684.","journal-title":"Nat Commun"},{"key":"2682_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","volume":"38","author":"R Moncada","year":"2020","unstructured":"Moncada R, et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat Biotechnol. 2020;38:333\u201342.","journal-title":"Nat Biotechnol"},{"key":"2682_CR18","doi-asserted-by":"crossref","unstructured":"Larsson L, Franz\u00e9n L, St\u00e5hl PL, Lundeberg J. Semla: a versatile toolkit for spatially resolved transcriptomics analysis and visualization. Bioinformatics. 2023;39(10).","DOI":"10.1093\/bioinformatics\/btad626"},{"key":"2682_CR19","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","volume":"3","author":"T Chu","year":"2022","unstructured":"Chu T, Wang Z, Pe\u2019er D, Danko CG. Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat Cancer. 2022;3:505\u201317.","journal-title":"Nat Cancer"},{"key":"2682_CR20","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","volume":"5","author":"YG Jeon","year":"2023","unstructured":"Jeon YG, Kim YY, Lee G, Kim JB. Physiological and pathological roles of lipogenesis. Nat Metab. 2023;5:735\u201359.","journal-title":"Nat Metab"},{"key":"2682_CR21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jhep.2020.08.036","volume":"74","author":"LK Chan","year":"2021","unstructured":"Chan LK, et al. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma. J Hepatol. 2021;74:360\u201371.","journal-title":"J Hepatol"},{"key":"2682_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/HEP.0000000000000553","volume":"79","author":"B Li","year":"2024","unstructured":"Li B, et al. Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma. Hepatology. 2024;79:289\u2013306.","journal-title":"Hepatology"},{"key":"2682_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78:770\u201382.","journal-title":"J Hepatol"},{"key":"2682_CR24","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13:1742.","journal-title":"Nat Commun"},{"key":"2682_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13059-024-03428-y","volume":"25","author":"E Withnell","year":"2024","unstructured":"Withnell E, Secrier M. SpottedPy quantifies relationships between spatial transcriptomic hotspots and uncovers environmental cues of epithelial-mesenchymal plasticity in breast cancer. Genome Biol. 2024;25:289.","journal-title":"Genome Biol"},{"key":"2682_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma RY, Black A, Qian BZ. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43:546\u201363.","journal-title":"Trends Immunol"},{"key":"2682_CR27","doi-asserted-by":"crossref","unstructured":"Zhang Y, Guo Y, Liu Z, Sun Y, Yang X, Chen M, et al. Cancer cells co-opt an inter-organ neuroimmune circuit to escape immune surveillance. Cell. 2025;188(24):6754\u201373.e29.","DOI":"10.1016\/j.cell.2025.09.029"},{"key":"2682_CR28","doi-asserted-by":"publisher","first-page":"216507","DOI":"10.1016\/j.canlet.2023.216507","volume":"582","author":"G Chen","year":"2024","unstructured":"Chen G, Zheng D, Zhou Y, Du S, Zeng Z. Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma. Cancer Lett. 2024;582:216507.","journal-title":"Cancer Lett"},{"key":"2682_CR29","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1158\/0008-5472.CAN-24-3854","volume":"85","author":"J Lu","year":"2025","unstructured":"Lu J, et al. FADD Activation in hepatocellular carcinoma potentiates CD8\u2009+\u2009T-cell responses and sensitizes to immune checkpoint inhibitors. Cancer Res. 2025;85:3454\u201370.","journal-title":"Cancer Res"},{"key":"2682_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-025-02314-w","volume":"24","author":"F Zeng","year":"2025","unstructured":"Zeng F, Zhang Q, Tsui YM, Ma H, Tian L, Husain A, et al. Multimodal sequencing of neoadjuvant nivolumab treatment in hepatocellular carcinoma reveals cellular and molecular immune landscape for drug response. Mol Cancer. 2025;24(1):110.","journal-title":"Mol Cancer"},{"key":"2682_CR31","doi-asserted-by":"crossref","unstructured":"Dadey RE et al. Multiomics identifies tumor-intrinsic SREBP1 driving immune exclusion in hepatocellular carcinoma. J Immunother Cancer 13(2025).","DOI":"10.1136\/jitc-2025-011537"},{"key":"2682_CR32","doi-asserted-by":"publisher","first-page":"103564","DOI":"10.1016\/j.redox.2025.103564","volume":"83","author":"J Wei","year":"2025","unstructured":"Wei J. Insights and perspectives on the role of APOC1 inhibition in modulating immunotherapy outcomes in HCC: Commentary on Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2025;83:103564.","journal-title":"Redox Biol"},{"key":"2682_CR33","doi-asserted-by":"publisher","first-page":"eado3485","DOI":"10.1126\/sciimmunol.ado3485","volume":"10","author":"J Liang","year":"2025","unstructured":"Liang J, et al. Riplet promotes lipid metabolism changes associated with CD8 T cell exhaustion and anti-PD-1 resistance in hepatocellular carcinoma. Sci Immunol. 2025;10:eado3485.","journal-title":"Sci Immunol"},{"key":"2682_CR34","doi-asserted-by":"publisher","first-page":"e14909","DOI":"10.1002\/advs.202414909","volume":"12","author":"T Wang","year":"2025","unstructured":"Wang T, Han L, Huo Y, Zhang L, Huang Y, Zhang N, et al. H3K36me3-Guided m(6)A Modification of Oncogenic L1CAM-AS1 Drives Macrophage Polarization and Immunotherapy Resistance in Hepatocellular Carcinoma. Adv Sci (Weinh). 2025;12(33):e14909.","journal-title":"Adv Sci (Weinh)"},{"key":"2682_CR35","doi-asserted-by":"crossref","unstructured":"Cheng K et al. Short-term starvation boosts anti-PD-L1 therapy by reshaping tumor-associated macrophages in hepatocellular carcinoma. Hepatology (2025).","DOI":"10.1097\/HEP.0000000000001244"},{"key":"2682_CR36","doi-asserted-by":"publisher","first-page":"e2413095","DOI":"10.1002\/advs.202413095","volume":"12","author":"J Cai","year":"2025","unstructured":"Cai J, et al. Lactylation-Driven NUPR1 Promotes immunosuppression of tumor-infiltrating macrophages in hepatocellular carcinoma. Adv Sci (Weinh). 2025;12:e2413095.","journal-title":"Adv Sci (Weinh)"},{"key":"2682_CR37","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1038\/s41467-025-61088-3","volume":"16","author":"L Cao","year":"2025","unstructured":"Cao L, et al. Adipocyte-specific Zeb1 downregulation remodels the tumor-associated adipose microenvironment to facilitate female breast cancer progression. Nat Commun. 2025;16:6011.","journal-title":"Nat Commun"},{"key":"2682_CR38","doi-asserted-by":"publisher","first-page":"1604156","DOI":"10.3389\/fimmu.2025.1604156","volume":"16","author":"S Tadic","year":"2025","unstructured":"Tadic S, Ochoa-Callejero L, Narro-\u00cd\u00f1iguez J, Garc\u00eda-Sanmart\u00edn J, Mart\u00ednez A. An RNA vaccine against adrenomedullin reduces angiogenesis and tumor burden in a syngeneic metastatic melanoma mouse model. Front Immunol. 2025;16:1604156.","journal-title":"Front Immunol"},{"key":"2682_CR39","first-page":"469","volume":"15","author":"G Albertin","year":"2005","unstructured":"Albertin G, et al. Endothelin-1 and adrenomedullin enhance the growth of human adrenocortical carcinoma-derived SW-13 cell line by stimulating proliferation and inhibiting apoptosis. Int J Mol Med. 2005;15:469\u201374.","journal-title":"Int J Mol Med"},{"key":"2682_CR40","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374:abe6474.","journal-title":"Science"},{"key":"2682_CR41","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14:979\u201382.","journal-title":"Nat Methods"},{"key":"2682_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16:284\u20137.","journal-title":"Omics"},{"key":"2682_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc. 2025;20:180\u2013219.","journal-title":"Nat Protoc"},{"key":"2682_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams M, et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell. 2022;185:379\u2013e396338.","journal-title":"Cell"},{"key":"2682_CR45","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/s41467-024-50904-x","volume":"15","author":"J Kueckelhaus","year":"2024","unstructured":"Kueckelhaus J, et al. Inferring histology-associated gene expression gradients in spatial transcriptomic studies. Nat Commun. 2024;15:7280.","journal-title":"Nat Commun"},{"key":"2682_CR46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41588-024-01664-3","volume":"56","author":"V Singhal","year":"2024","unstructured":"Singhal V, et al. BANKSY unifies cell typing and tissue domain segmentation for scalable spatial omics data analysis. Nat Genet. 2024;56:431\u201341.","journal-title":"Nat Genet"},{"key":"2682_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert M, et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat Commun. 2018;9:20.","journal-title":"Nat Commun"},{"key":"2682_CR48","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","volume":"75","author":"L Ma","year":"2021","unstructured":"Ma L, et al. Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol. 2021;75:1397\u2013408.","journal-title":"J Hepatol"},{"key":"2682_CR49","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi K, et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. 2021;39:649\u2013e661645.","journal-title":"Cancer Cell"},{"key":"2682_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun Y, et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. 2021;184:404\u2013e421416.","journal-title":"Cell"},{"key":"2682_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13059-022-02663-5","volume":"23","author":"J Tanevski","year":"2022","unstructured":"Tanevski J, Flores ROR, Gabor A, Schapiro D, Saez-Rodriguez J. Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol. 2022;23:97.","journal-title":"Genome Biol"},{"key":"2682_CR52","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/(SICI)1097-0258(19990830)18:16<2147::AID-SIM179>3.0.CO;2-I","volume":"18","author":"RM Assun\u00e7\u00e3o","year":"1999","unstructured":"Assun\u00e7\u00e3o RM, Reis EA. A new proposal to adjust Moran\u2019s I for population density. Stat Med. 1999;18:2147\u201362.","journal-title":"Stat Med"}],"updated-by":[{"DOI":"10.1186\/s12943-026-02777-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000}}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02682-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:58:23Z","timestamp":1788483503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02682-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2682"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02682-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12943-026-02777-5","URL":"https:\/\/doi.org\/10.1186\/s12943-026-02777-5","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human ethics and consent to participate declaration: All human experiments were approved by the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster (UW 17\u2013056).The animal experiment was approved by the Committee on the Use of Live Animals in Teaching and Research (CULATR 23-211), Li Ka Shing Faculty of Medicine, University of Hong Kong.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"190"}}